Analyst firms · Evercore ISI · HOLX
Evercore ISI HOLX price target and rating history
Hologic Inc. (HOLX) · Health Care
Evercore ISI rates Hologic Inc. (HOLX) In-line with a $78 price target, as of its latest action on Jan 5, 2026. It has published 4 rating actions on HOLX since July 2021, including 2 upgrades and 2 downgrades.
- Current rating
- In-line
- Price target
- $78
- Median target, all firms
- Too few
- Actions on HOLX
- 4
Evercore ISI price target on HOLX
Every Evercore ISI rating on HOLX
- Jan 5, 2026
- Oct 7, 2025
- Apr 4, 2022
- Jul 6, 2021
How other firms rate HOLX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Argus Research | Hold | Jan 12, 2026 | |
| Evercore ISI | In-line | $78 | Jan 5, 2026 |
| BNP Paribas Exane | Neutral | $79 | Nov 21, 2025 |
Questions about Evercore ISI and HOLX
- What is Evercore ISI's price target for HOLX?
- Evercore ISI's latest stated price target for Hologic Inc. (HOLX) is $78, from its action on Jan 5, 2026.
- What is Evercore ISI's rating on HOLX?
- Evercore ISI rates HOLX In-line, a neutral rating, as of Jan 5, 2026.
- When did Evercore ISI last change its view on HOLX?
- On Jan 5, 2026, Evercore ISI downgrades to In-line from Outperform, price target $78.
More HOLX rating histories
All Evercore ISI ratingsHOLX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.